Metastatic Crohn's disease: remission induced by mesalamine and prednisone.
We describe a patient with cutaneous Crohn's disease with extensive cutaneous ulcerations preceding the diagnosis of gastrointestinal Crohn's. The cutaneous lesions responded to mesalamine and prednisone. The patient has been maintained on a regimen of mesalamine alone without recurrence. We discuss available forms of mesalamine and their function in cutaneous disease.
Gilson
M R
MR
Department of Dermatology, Wilford Hall Medical Center/Brooke Army Medical Center, San Antonio, Texas, USA.
Elston
L C
LC
Pruitt
C A
CA
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001706:Biopsy; D003424:Crohn Disease / Q000150:complications*; D004359:Drug Therapy, Combination; D004890:Erythema / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006801:Humans; D008297:Male; D019804:Mesalamine / Q000008:administration & dosage*; D011241:Prednisone / Q000008:administration & dosage*; D012074:Remission Induction; D012867:Skin / Q000473:pathology; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine; D011241:Prednisone